Skip to main content
. Author manuscript; available in PMC: 2014 Jul 3.
Published in final edited form as: Bone Marrow Transplant. 2009 Aug 10;45(3):429–436. doi: 10.1038/bmt.2009.189

Figure 1.

Figure 1

Cumulative incidence of non-relapse mortality and disease progression for patients with AML undergoing haploidentical SCT with fludarabine, melphalan and thiotepa and ATG preparative regimen.